New development in anticoagulant and antithrombotic therapy: are we on the right track?
Fareed
Jawed
J
D000925:Anticoagulants / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight; D006801:Humans; D013917:Thrombin / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D013917:Thrombin